The Business Times

Australia: Shares rise on hopes for quick economic recovery

Published Wed, Jun 17, 2020 · 07:40 AM
Share this article.

[SYDNEY] Australian shares advanced on Wednesday as hopes for a swift global economic recovery rose after a record jump in US retail sales, although fears of a second wave of coroanvirus cases capped gains.

The S&P/ASX 200 index rose 0.83 per cent to 5,991.8 points at the close of trade. The benchmark rose 3.9 per cent on Tuesday.

US retail sales rebounded sharply in May after two months of declines, spurring hopes that the virus-induced recession may be drawing to an end.

The optimism, however, was crimped by a resurgence in coronavirus cases as Beijing cut flights and closed schools in a bid to contain another outbreak, while new infections hit record highs in six US states.

Australia also said it will continue restrictions on its international borders for "some time to come".

"Even as the Covid-19 cases continue to be noted across the world, the sentiment is suggesting that expectations remain for continued recovery particularly judging the fact that governments may be unwilling to see to an expansive lockdown once again," Jingyi Pan, market strategist at IG, said.

GET BT IN YOUR INBOX DAILY

Start and end each day with the latest news stories and analyses delivered straight to your inbox.

VIEW ALL

Leading the gains in Australia, tech stocks jumped to their highest level since February 19 after Wall Street peers rallied overnight.

New Zealand's benchmark S&P/NZX 50 index rose 3.5 per cent to finish the session at 11,334.31.

The country on Wednesday formally launched talks on free trade agreements with Britain, which is looking to line up post-Brexit trade deals with other countries.

REUTERS

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Capital Markets & Currencies

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here